ArticleBMC urology2026
CT and MRI features of renal inflammatory myofibroblastic tumor and its differential diagnosis from clear cell renal cell carcinoma and chromophobe renal cell carcinoma: a study of 13 cases from two centers.
Article in BMC urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundTo compare the CT and MRI features of renal inflammatory myofibroblastic tumor (IMT) with those of clear cell renal cell carcinoma (ccRCC) and chromophobe renal cell carcinoma (ChRCC).
methodsClinical and imaging data of 13 patients with pathologically confirmed renal IMT, along with 52 patients with ccRCC and 52 with ChRCC treated at two centers between January 2013 and February 2025 were retrospectively obtained, and the lesions' location, shape, margin, size, secondary changes, density or signal characteristics, and enhancement degree with pattern were analyzed. The clear cell likelihood score (ccLS) was used for the evaluation of MRI characteristics.
resultsThe renal IMT cohort comprised 9 males and 4 females (mean age, 54.2 ± 8.61 years). All lesions were solitary, measuring 1.7-14.4 cm. Notably, ill-defined margins were detected in 9/13 (69.2%), perirenal fascia thickening in 8/13 (61.5%), and non-enhancing region in 3/13 (23.1%). There was no hemorrhage, central scar or calcification. Unenhanced CT showed a mean attenuation of 43.7 HU. On contrast-enhanced CT, 77.8% (7/9) exhibited mild-moderate enhancement, with 55.6% (5/9) showing progressive enhancement and 33.3% (3/9) demonstrating a "slow-in and slow-out" pattern. MRI revealed hypointense or isointense signal on T1WI and T2WI, while 87.5% (7/8) showed restricted diffusion on DWI and arterial-to-delayed enhancement ratio < 1.5. No lesions exhibited microscopic fat or segmental enhancement inversion. The ccLS for renal IMTs were predominantly 1-2. Compared to ccRCCs and ChRCCs, renal IMTs more commonly exhibited ill-defined margins (P1 = 0.037, P2 < 0.001), perirenal fascia thickening (P1 = 0.014, P2 < 0.001) and higher unenhanced CT attenuation (P1 = 0.016, P2 = 0.030). Two renal IMT cases showed suspected postoperative recurrence or metastasis.
conclusionsCT and MRI imaging features can facilitate the diagnosis of renal IMT and differentiate it from ccRCC and ChRCC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.